Dr. Michelle Miller

Michelle is a research scientist with a productive history of project management, bringing with her a diverse background in chemistry/biochemistry, immunology, and toxicology that provides a strong foundation for creative experimental design and problem solving. Prior to joining BioAgilytix, Michelle was a Study Director at Burleson Research Technologies (BRT), where she led development of novel immunoassays for preclinical and clinical GxP studies. Her previous experience includes time spend as a lead investigator in the toxicology field, developing high throughput screening assays, and as an R&D scientist in the pharmaceutical industry. She is a current Diplomate of the American Board of Toxicology and an active member of the immunotoxicology specialty section of SOT.

In her role at BioAgilytix, Michelle works closely with clients to assure successful on time execution of assays, validation, and sample analysis under GxP, supporting preclinical, clinical, and product release studies. Michelle received a BA in Chemistry, BS in Zoology, and PhD in Immunology with a minor in Biochemistry from North Carolina State University.